Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 2768Carcinoma, Non-Small-Cell Lung 2267Prostatic Neoplasms 1427Colorectal Neoplasms 1295Neoplasms 1260Multiple Myeloma 1086Lung Neoplasms 1050Neoplasm Metastasis 995Leukemia, Myeloid, Acute 985Lymphoma 900Melanoma 864Pancreatic Neoplasms 819Ovarian Neoplasms 805Carcinoma, Hepatocellular 782Stomach Neoplasms 754Recurrence 753Leukemia 733Lymphoma, Non-Hodgkin 685Leukemia, Lymphocytic, Chronic, B-Cell 665Squamous Cell Carcinoma of Head and Neck 618Lymphoma, Large B-Cell, Diffuse 617Precursor Cell Lymphoblastic Leukemia-Lymphoma 605Head and Neck Neoplasms 599Brain Neoplasms 593Carcinoma, Renal Cell 587Glioblastoma 573Rectal Neoplasms 565Sarcoma 523Myelodysplastic Syndromes 522Lymphoma, Follicular 516

Interventions

apatinib 2tyrosyl-glutamyl-tryptophan 1Platinum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Advanced Esophagus Cancer × Clear all
NCT03542422 2018-06-14

Apatinib as First -Line Treatment for Advanced Esophagus Cancer

Affiliated Hospital of North Sichuan Medical College

Phase 2 Unknown
50 enrolled
Gastrointestinal

Advanced Esophagus Cancer

NCT03170310 2017-05-31

Apatinib Treatment for Advanced Esophagus Cancer

Henan Cancer Hospital

Phase 2 Unknown
60 enrolled
Gastrointestinal

Advanced Esophagus Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡